• Science4Beauty raised PLN 7 million in a private financing round led by 4Growth VC, with participation from Hard2beat, business angels.
• Polish biotech develops patented recombinant proteins for medical-grade skincare, dermatology, aesthetic medicine; lead product uses a conotoxin-based “botox-in-a-cream” active.
• Proceeds will scale sales, advance additional bioactive molecules, fund international expansion.
• The company reported more than PLN 500,000 in 2025 revenue from five products, with distribution via clinics and direct-to-consumer e-commerce.
• Prior R&D was supported by more than PLN 10 million in NCBR grants, reducing technology risk.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4Growth VC Sp. z o.o. published the original content used to generate this news brief on September 03, 2026, and is solely responsible for the information contained therein.